Engaging with Clients Across Switzerland

17 February 2025

Last week, we had the pleasure of visiting clients in Zurich, Zug, and Bern, connecting with a diverse mix of big pharma, mid-sized companies, and smaller biotech companies across Switzerland’s stunning landscape.

As Pharma Insiders with Impact, we engaged in discussions covering a wide range of strategic priorities — from establishing an RWE Center of Excellence and integrating evidence generation processes at a mid-sized pharma company to supporting biotech firms in building new entities from the ground up, including commercial and Medical Affairs functions in Western Europe. Meanwhile, large pharma companies continue to seek support in bridging the execution of RWE studies with Medical Affairs strategies.

Therapy areas spanned oncology, metabolic diseases, and rare diseases, reflecting the broad and evolving needs of the industry.

At InnoStrat, we take pride in enabling our clients to elevate their Medical Affairs functions, ensuring they are equipped to bridge external insights with internal strategies.

We look forward to continuing these impactful collaborations!